Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Universe Pharmaceuticals Inc UPC

Healthcare Drug Manufacturers - Specialty & Generic
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sells of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:UPC)

Universe Pharmaceuticals INC Announces Share Consolidation

GlobeNewswire March 20, 2025

Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report

GlobeNewswire February 25, 2025

Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request

GlobeNewswire February 3, 2025

Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering

GlobeNewswire December 9, 2024

Universe Pharmaceuticals INC Announces Share Consolidation

GlobeNewswire November 13, 2024

Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

GlobeNewswire November 1, 2024

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024

GlobeNewswire September 20, 2024

Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results

PR Newswire January 30, 2024

Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares

GlobeNewswire August 4, 2023
View More News ››

Opinion & Analysis (NDAQ:UPC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:UPC)

Still staying with this stock.

It is starting a new uptrend for shareholders today anyway,so good luck to all of you guys.
coolfooldumbguy - 4 days ago

UPC.....Bot that Dip and sold that Rip

1st scalp of the day Gracias!
Iseneschal - October 9, 2025

RE:UPC....last bastion of support at $7.20

Now trading at $5.84 this a.m in PM trading
Iseneschal - October 9, 2025

UPC....last bastion of support at $7.20

You've all been had.....again
Iseneschal - October 8, 2025

RE:RE:UPC....I started a small position just above the $8.30 pivot

Come on Mr. M ....make my day !
Iseneschal - October 8, 2025

RE:UPC....I started a small position just above the $8.30 pivot

haha....the Maggot did this before.....drops it thru the support then sends ....right ?
Iseneschal - October 8, 2025
View more Bullboard ››

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms ...
View More »